Low Molecular Weight Fucoidan Prevents Neointimal Hyperplasia After Aortic Allografting
- 15 May 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 83 (9), 1234-1241
- https://doi.org/10.1097/01.tp.0000261109.97928.9c
Abstract
Background. Fucoidan, a new low molecular weight sulfated polysaccharide (LMWF), has previously been shown to mobilize bone marrow-derived progenitors cells via stimulation of stromal derived factor (SDF)-1 release. Mobilized progenitor cells have been suggested to repair intimal lesions after immune-mediated endothelial injury and thus prevent intimal proliferation. The aim of this study was to evaluate the effect of LMWF treatment in a rat aortic allograft model of transplant arteriosclerosis (TA). Methods. Aortic grafts were performed in Brown Norway (BN, donor) and Lewis (Lew, recipient) rats. The recipient rats were treated with LMWF (5 mg/kg/day) and sacrificed at 30 days. To determine the role of SDF-1 in mediating the effects of LMWF, a specific inhibitor of the SDF-1 receptor CXCR4, AMD 3100 (20 μg/kg/day), was used. The grafted segments were evaluated by morphometric (histochemical) analyses. Results. Untreated aortic allografts exhibited severe intimal proliferation, indicative of TA. In contrast, LMWF treatment significantly prevented allograft intimal proliferation as compared with controls (5.7±3 vs. 66.2±6 μm, PP<0.01). Further, LMWF treatment stimulated allograft reendothelialization, as evidenced by strong intimal endothelial nitric oxide synthase antibody and CD31 signals. Unexpectedly, AMD treatment failed to prevent the protective effect of LMWF on intimal thickening and AMD treatment alone was found to reduced intimal proliferation in allografts. Conclusions. We found that LMWF treatment reduced intimal thickness and induced the presence of an endothelial cell lining in the vascular graft at 30 days. Our findings may suggest a novel therapeutic strategy in the prevention of TA.Keywords
This publication has 42 references indexed in Scilit:
- Transplant Graft VasculopathyCirculation, 2003
- Circulating Vascular Progenitor Cells Contribute to Vascular Repair, Remodeling, and Lesion FormationTrends in Cardiovascular Medicine, 2003
- Origin of Vascular Smooth Muscle Cells and the Role of Circulating Stem Cells in Transplant ArteriosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Smooth Muscle Cells, But Not Myocytes, of Host Origin in Transplanted Human HeartsCirculation, 2002
- Neointimal and Tubulointerstitial Infiltration by Recipient Mesenchymal Cells in Chronic Renal-Allograft RejectionNew England Journal of Medicine, 2001
- Vascular Smooth Muscle Cells of Recipient Origin Mediate Intimal Expansion after Aortic Allotransplantation in MiceThe American Journal of Pathology, 2001
- Origin of neointimal endothelium and α-actin–positive smooth muscle cells in transplant arteriosclerosisJCI Insight, 2001
- Circulating Bone Marrow Cells Can Contribute to Neointimal FormationJournal of Vascular Research, 2001
- SEQUENTIAL IMMUNOLOGICAL TARGETING OF CHRONIC EXPERIMENTAL ARTERIAL ALLOGRAFTTransplantation, 1995
- Pathophysiology of vascular wall changes in chronic allograft rejectionTransplantation Reviews, 1993